These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4615850)

  • 21. Local immunological response in the vagina, cervix and endometrium.
    Vaerman JP; Férin J
    Acta Endocrinol Suppl (Copenh); 1975; 194():281-305. PubMed ID: 1092117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody activity to type 1 and type 2 herpes simplex virus in human cervical mucus.
    Coughlan BM; Skinner GR
    Br J Obstet Gynaecol; 1977 Aug; 84(8):622-9. PubMed ID: 196613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble membrane antigens of lip and cervical carcinomas: reactivity with antibody for herpesvirus nonvirion antigens.
    Hollinshead AC; Tarro G
    Science; 1973 Feb; 179(4074):698-700. PubMed ID: 4734354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactivity between herpesvirus type 2-related soluble cervical tumor cell membrane antigens and matched cancer and control sera.
    Hollinshead A; Lee OB; McKelway W; Melnick JL; Rawls WE
    Proc Soc Exp Biol Med; 1972 Nov; 141(2):688-93. PubMed ID: 4564620
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for chronic viral infections in human arteries.
    Smith KO; Gehle WD; Sanford BA
    Proc Soc Exp Biol Med; 1974 Nov; 147(2):357-60. PubMed ID: 4373754
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunoglobulin type of anti-Candida albicans antibodies in candidal vaginitis.
    Segal E; Vardinon N; Foldes J
    Zentralbl Bakteriol Orig A; 1978 Nov; 242(2):265-7. PubMed ID: 367007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to herpesvirus type 2 in carcinoma of the cervix uteri in Ibadan, Nigeria.
    Adelusi B; Osunkoya BO; Fabiyi A
    Am J Obstet Gynecol; 1975 Dec; 123(7):758-61. PubMed ID: 1106197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals.
    Zhu XX; Zeng Y; Wolf H
    Int J Cancer; 1986 May; 37(5):689-91. PubMed ID: 3009331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical and serum IgA and serum IgG antibodies to Chlamydia trachomatis and herpes simplex virus in threatened abortion: a prospective study.
    Grönroos M; Honkonen E; Terho P; Punnonen R
    Br J Obstet Gynaecol; 1983 Feb; 90(2):167-70. PubMed ID: 6297535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical uses of the diagnostic virology laboratory.
    Smith TF
    Med Clin North Am; 1983 Sep; 67(5):935-51. PubMed ID: 6312218
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of local infection and oral contraception on immunoglobulin levels in cervical mucus.
    Chipperfield EJ; Evans BA
    Infect Immun; 1975 Feb; 11(2):215-21. PubMed ID: 163217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Criteria for the differentiation of lymphoid cell lines.
    von Heyden HW; von Heyden D
    Blut; 1974 Nov; 29(5):323-31. PubMed ID: 4371891
    [No Abstract]   [Full Text] [Related]  

  • 33. Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls.
    Aurelian L; Cornish JD; Smith MF
    IARC Sci Publ (1971); 1975; (11 Pt 2):79-87. PubMed ID: 191387
    [No Abstract]   [Full Text] [Related]  

  • 34. Spermatozoal antibodies in cervical mucus.
    Coelingh Bennink HJ; Menge AC
    Eur J Obstet Gynecol Reprod Biol; 1974; 4(4):147-52. PubMed ID: 4614993
    [No Abstract]   [Full Text] [Related]  

  • 35. Techniques for eliciting mucosal immune response.
    Waldman RH; Ganguly R
    Acta Endocrinol Suppl (Copenh); 1975; 194():262-80. PubMed ID: 804792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum immunoglobulin profile in patients with cancer cervix.
    Gupta SC; Singh PA; Shukla HS; Mehrotra TN
    Indian J Med Res; 1980 Jun; 71():893-6. PubMed ID: 7419253
    [No Abstract]   [Full Text] [Related]  

  • 37. Neutralization, immunofluorescence and complement fixation tests in identification of antibody to a herpesvirus type 2-induced, tumor-specific antigen in sera from squamous cervical carcinoma.
    Aurelian L; Strandberg JD; Marcus RL
    Prog Exp Tumor Res; 1974; 19():165-81. PubMed ID: 4612606
    [No Abstract]   [Full Text] [Related]  

  • 38. Heterogeneous enzyme immunoassay: detection of anti-Candida albicans specific Ig-isotypes and mannan antigen.
    Paulovicová E; Sandula J
    Mykosen; 1986 Sep; 29(9):393-8. PubMed ID: 3534563
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibodies to herpesvirus type 1 and type 2 among Japanese cervical cancer patients.
    Ozaki Y; Ishiguro T; Ohashi M; Sawaragi I; Ito Y
    Gan; 1978 Feb; 69(1):119-22. PubMed ID: 640320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.